Danielle Roy/X
Dec 18, 2025, 09:49
Clotting and Bleeding Risks in Cancer: Links to Inflammatory and Cardiac Biomarkers by Danielle Roy et al.
Danielle Roy, Clinical Research Assistant at Health Sciences North Research Institute, shared on X:
“Cancer patients face competing risks of clotting and bleeding. Our new European Heart Journal study shows associations with inflammatory and cardiac biomarkers.”
Title: Venous thromboembolism and bleeding in cancer patients: role of inflammatory and cardiac biomarkers
Authors: Danielle Carole Roy, Tzu-Fei Wang, Ranjeeta Mallick, Dylan Burger, Marc Carrier, Philip Wells, Steven Hawken.
Find more posts on Hemostasis Today.
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’
-
Jul 7, 2026, 20:59William Aird: An Unlucky Turn Into the Renal Artery
-
Jul 7, 2026, 20:58Chokri Ben Lamine: The Two-Hit Model of TRALI
-
Jul 7, 2026, 20:57New Issue of Blood Out Now – Blood Journals Portfolio
-
Jul 7, 2026, 20:56Priyadarshini Ramakrishnan: Schistocytes – The Most “Misleading Heroes” in a Peripheral Smear